The UNC School of Medicine and NC TraCS announce labs selected for $50,000 pilot grants to further Alzheimer’s Disease.


Three teams received the 2017 SOM funded ECBR grants. This year’s focus was Alzheimer’s Disease. The interdisciplinary teams use a diversity of techniques and approaches to Alzheimer’s pathology and therapy. The 2017 ECBR projects are:

Rich Meeker, PhD (Neurology) and Todd Cohen, PhD (Neurology) are Co-PIs leading a team of investigators on a project titled Inflammation, Aging and Alzheimer’s Disease Vulnerability. Other team members include Paul Carney, MD (Pediatric Neurology), Tom DeMarse, PhD (Neurology), Zibo Li, PhD (Radiology), Hong Yuan, PhD (Radiology) and Sheryl Moy, PhD (Psychiatry).

Mohanish Deshmuhk, PhD (Cell Biology & Physiology) and Todd Cohen, PhD (Neurology) are Co-PIs of the project titled Strategies from the Healthy Brain for Alzheimer’s Disease: Focus on MiR-29.

Aravid Asokan, PhD (Genetics) and Juan Song, PhD (Pharmacology) are Co-PIs of the project titled Aquaporin gene therapy for Alzheimer’s Disease.

For more information on the ECBR grants click here. To read the announcement about the 2017 ECBR grants in Vital Signs click here